The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20179232

Clin. Cancer Res. 2010 Mar 1 16 5 1613-23

Download in:

View as

Triples

General Info

PMID
20179232